Cargando…
Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy
Coronavirus disease 2019 (COVID-19) is a globally communicable public health disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV-2). Eradication of COVID-19 appears practically impossible but, therefore, more effective pharmacotherapy is needed. The deteriorated clinical pres...
Autor principal: | Shibabaw, Tewodros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547786/ https://www.ncbi.nlm.nih.gov/pubmed/33116747 http://dx.doi.org/10.2147/JIR.S278335 |
Ejemplares similares
-
The role of Th-17 cells and IL-17 in the metastatic spread of breast cancer: As a means of prognosis and therapeutic target
por: Shibabaw, Tewodros, et al.
Publicado: (2023) -
Signalling of multiple interleukin (IL)‐17 family cytokines via IL‐17 receptor A drives psoriasis‐related inflammatory pathways
por: Tollenaere, M.A.X., et al.
Publicado: (2021) -
TRAF Regulation of IL-17 Cytokine Signaling
por: Swaidani, Shadi, et al.
Publicado: (2019) -
Pivotal Roles of T-Helper 17-Related Cytokines, IL-17, IL-22, and IL-23, in Inflammatory Diseases
por: Qu, Ning, et al.
Publicado: (2013) -
The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases
por: Kuwabara, Taku, et al.
Publicado: (2017)